European Respiratory Society

The impact of seat height on 1-min sit-to-stand test performance in COPD: a randomised crossover trial
Performing the 1MSTS test on an individually adjusted chair versus a standard chair results in fewer repetitions (mean difference −0.78, 95% CI −1.47 to −0.11). However, the difference in repetitions is clinically negligible.
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
This longitudinal study supports the recent updates to the CTS and GINA guidelines for asthma care. SABA utilisation can be used to identify patients at higher risk of severe exacerbation, regardless of disease severity.
Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific
The presence of Haemophilus influenzae, Moraxella catarrhalis or human rhinovirus in sputum samples significantly increases the odds of an exacerbation, as opposed to being in stable state, in COPD
Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
Patients with the PI*ZZ genotype have more severe pulmonary disease than those with the PI*SZ genotype. However, asthma is as frequent in PI*SZ as in PI*ZZ.
Advances in diagnostic tools for respiratory tract infections: from tuberculosis to COVID-19 – changing paradigms?
Unprecedented advances have been achieved by improving and applying the latest technologies to key aspects such as epidemiology, contact tracing and diagnostics of respiratory tract infections that need to be properly addressed for global improvements

Latest Articles

Respiratory healthcare professionals’ views on long-term recommendations of interventions to prevent acute respiratory illnesses after the COVID-19 pandemic
Karin Yaacoby-Bianu, Galit Livnat, James D. Chalmers, Michal Shteinberg

ERJ Open Research Oct 2022, 8 (4) 00114-2022; DOI: 10.1183/23120541.00114-2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Håkansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg

ERJ Open Research Oct 2022, 8 (4) 00238-2022; DOI: 10.1183/23120541.00238-2022
Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
Johannes A. Kroes, Aruna T. Bansal, Emmanuelle Berret, Nils Christian, Andreas Kremer, Anna Alloni, Matteo Gabetta, Chris Marshall, Scott Wagers, Ratko Djukanovic, Celeste Porsbjerg, Dominique Hamerlijnck, Olivia Fulton, Anneke ten Brinke, Elisabeth H. Bel, Jacob K. Sont

ERJ Open Research Oct 2022, 8 (4) 00168-2022; DOI: 10.1183/23120541.00168-2022
“Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges”. Namrata Kewalramani, Carlos Machahua, Venerino Poletti, Jacques Cadranel, Athol U. Wells and Manuela Funke-Chambour. ERJ Open Res 2022; 8: 00115-2022.
ERJ Open Research Jul 2022, 8 (3) 50115-2022; DOI: 10.1183/23120541.50115-2022
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
Stephen G. Noorduyn, Christina Qian, Karissa M. Johnston, Mena Soliman, Manisha Talukdar, Brandie L. Walker, Paul Hernandez, Erika Penz

ERJ Open Research Jul 2022, 8 (3) 00140-2022; DOI: 10.1183/23120541.00140-2022
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
Toru Arai, Yoshikazu Inoue

ERJ Open Research Jul 2022, 8 (3) 00242-2022; DOI: 10.1183/23120541.00242-2022

About ERJ Open Research

ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. It has a Journal Impact Factor of 4.2.

Tweets by @ERSpublications

Main menu

User menu

Search

Latest Articles

About ERJ Open Research

Contact us